from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2718c/nrdR

LFCtreatmentdescriptionclass of inhibitor

0.969

Amikacinug/mL Amikacintranslation

0.153

Cap5-10ug/mL Capreomycintranslation

-0.030

Rox10-50 ug/mL Roxithromycintranslation

0.418

SM2-5 ug/mL Streptomycintranslation

2.023

Tet5-10 ug/mL Tetracyclinetranslation

0.522

Rif0.2-5ug/mL Rifampicintranscription

-0.087

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.831

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.232

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.110

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.222

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.684

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.229

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.029

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.628

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.596

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.432

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.151

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.025

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.792

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.401

KCN5-20 ug/mL Potassium cyaniderespiration

-0.489

NaN30.2-2 mM Sodium aziderespiration

-0.940

Nigericin50 uM Nigericinrespiration

-0.309

TRC10-150 ug/mL Triclosanrespiration

-0.083

TRZ10-25 ug/mL Thioridazinerespiration

-0.367

Valinomycin0.5-10 uM Valinomycinrespiration

-0.552

ZnSO42 mM ZnSO4respiration

-0.398

menadione6-10 ug/mL Menadionerespiration

-0.546

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.403

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.078

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.360

NRP_1Non-replicating persistence stage 1dosRassociated

0.571

Amp0.2mg/mL AmpicillincellWall

-0.305

Cephalexin20-100 ug/mL CephalexincellWall

-0.346

Cerulenin0.32-5 ug/mL CerulenincellWall

0.212

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.219

EMB10-20 ug/mL EthambutolcellWall

1.030

Eta12-40 ug/mL EthionamidecellWall

-0.014

INH0.2-0.4 ug/mL IsoniazidcellWall

0.260

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.764

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.379

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.313

BZA0.12 mg/mL BenzamidearomaticAmides

-0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.106

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.529

H2O24 mM hydrogen peroxideDNAdamaging

0.316

Levo10 ug/mL LevofloxacinDNAdamaging

1.004

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.163

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.914

Oflox5-10 ug/mL OfloxacinDNAdamaging

2.478

UVUV-irradiationDNAdamaging

0.802

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.537

Antimycin12.5-50 ug/mL Antimycin A?

-0.712

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.363

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.375

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.141

PA8240.2-2 ug/mL PA-824?

0.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.321

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.591

Verapamil50 uM Verapamil?

-0.640

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.439

methoxatin10-20 ug/mL Methoxatin?